* Biotricity Inc BTCY.OQ reported a quarterly adjusted
loss of 9
cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 9 cents per
share.
* Revenue rose 27.5% to $2.74 million from a year ago;
analysts
expected $2.60 million.
* Biotricity Inc's reported EPS for the quarter was a loss
of 9
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Biotricity Inc shares had risen by 34.8% this quarter and
gained 39.9% so far this year.
* The company reported a quarterly loss of $4.86 million.
* Wall Street's median 12-month price target for Biotricity
Inc is
$2.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data June
30 at 09:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.09 -0.09 Met
Dec. 31 2022 -0.09 -0.09 Met
Sep. 30 2022 -0.07 -0.09 Missed
Jun. 30 2022 -0.11 -0.10 Beat